Патогенетическое значение сосудистого эндотелиального фактора роста при псориазе
DOI:
https://doi.org/10.15587/2313-8416.2016.61155Słowa kluczowe:
псориаз вульгарный, патогенез, ангиогенез, сосудистый эндотелиальный фактор роста, клинические проявленияAbstrakt
Изучено содержание сосудистого эндотелиального фактора роста (VEGF) в крови 35 больных псориазом. Выявлено повышение уровня VEGF в 3,4–7,9 раза в зависимости от стадии, распространенности, степени тяжести, длительности и частоты обострений дерматоза. Установлена прямая корреляционная зависимость между VEGF, индексом распространенности и тяжести псориаза, частотой рецидивов. Обсуждается роль VEGF в патогенезе псориаза
Bibliografia
Bolotnaja, L. A. et. al; Bolotnaja, L. A. (Ed.) (2015). Prakticheskaja dermatologija. Kharkiv: S.A.M., 278.
Kondrat'eva, N. N., Rasskazov, Ja. A., Bakulev, A. L. (2013). Terapija bol'nyh psoriazom: sovremennyj vzgljad na problemu. Prakticheskaja medicina, 1-4 (13), 28–32.
Sprindzhuk, M. V. (2010). Angiogenez. Morfologіja, ІV (3), 4–13.
Canavese, M., Schauber, J. (2011). Vascular Endothelial Growth Factor and Psoriasis Pathogenesis: Major Culprit, Treatment Target, or Possible Biomarker? International Journal of Clinical Reviews. doi: 10.5275/ijcr.2011.07.05
Young, H., Weidmann, A., Crawshaw, A., Byrne, E. (2013). Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clinical, Cosmetic and Investigational Dermatology, 233. doi: 10.2147/ccid.s35312
Olisova, O. Ju., Kochergin, N. G., Vertieva, E. Ju. (2013). Androgeneticheskaja alopecija. Rossijskij zhurnal kozhnyh i venericheskih boleznej, 3, 53–57.
Carmeliet, P. (2005). Angiogenesis in life, disease and medicine. Nature, 438 (7070), 932–936. doi: 10.1038/nature04478
Ibragimov, O. D. (2008). Patomorfologicheskie pokazateli proliferativnoj aktivnosti kozhi u bol'nyh psoriazom. Novosti dermatovenerologii i reproduktivnogo zdorov'ja, 4, 87–92.
Kuroda, K., Sapadin, A., Shoji, T., Fleischmajer, R., Lebwohl, M. (2001). Altered Expression of Angiopoietins and Tie2 Endothelium Receptor in Psoriasis. Journal of Investigative Dermatology, 116 (5), 713–720. doi: 10.1046/j.1523-1747.2001.01316.x
Walsh, D. A. (2007). Pathophysiological Mechanisms of Angiogenesis. Advances in Clinical Chemistry, 187–221. doi: 10.1016/s0065-2423(07)44006-9
Tolmacheva, N. V., Anisimova, A. S. (2015). Sovremennyj vzgljad na jetiologiju i patogenez psoriaza. Fundamental'nye issledovanija, 1, 2118–2121.
Raut, A. S., Prabhu, R. H., Patravale, V. B. (2013). Psoriasis Clinical Implications and Treatment: A Review. Critical Reviews in Therapeutic Drug Carrier Systems, 30 (3), 183–216. doi: 10.1615/critrevtherdrugcarriersyst.2013005268
Smol'nikova, N. V., Smirnova, S. V., Barilo, A. A. (2015). Osobennosti immunopatogeneza psoriaza i psoriaticheskogo artrita. Fundamental'nye issledovanija, 1-7, 1443–1447.
Ajvazova, T. V., Kushlinskij, N. E., Perlamutrov, Ju. N. (2008). Osobennosti angiogeneza bol'nyh jekssudativnoj formoj psoriaza. Klinicheskaja dermatologija i venerologija, 3, 8–11.
Marina, M. E., Roman, I. I., Constantin, A.-M., Mihu, C. M., Tătaru, A. D. (2015). VEGF involvement in psoriasis. Clujul Medical, 88 (3), 247. doi: 10.15386/cjmed-494
Namazova, L. S., Mazitova, L. P., Murashkin, N. N. (2009). Osobennosti angiogeneza i obosnovanie patogeneticheskoj terapii u detej, stradajushhih psoriazom. Vestnik dermatologii i venerologii, 1, 81–87.
Detmar, M. (2004). Evidence for Vascular Endothelial Growth Factor (VEGF) as a Modifier Gene in Psoriasis. Journal of Investigative Dermatology, 122 (1), xiv–xv. doi: 10.1046/j.0022-202x.2003.22140.x
Young, H. S., Bhushan, M., Griffiths, C. E. M., Summers, A. M., Brenchley, P. E. C. (2004). Single-Nucleotide Polymorphisms of Vascular Endothelial Growth Factor in Psoriasis of Early Onset. Journal of Investigative Dermatology, 122 (1), 209–215. doi: 10.1046/j.0022-202x.2003.22107.x
Markham, T., Mullan, R., Golden-Mason, L., Rogers, S., Bresnihan, B., FitzGerald, O. et. al (2006). Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy. Journal of the American Academy of Dermatology, 54 (6), 1003–1012. doi: 10.1016/j.jaad.2006.01.038
Creamer, D., Allen, M., Jaggar, R., Stevens, R., Bicknell, R., Barker, J. (2002). Mediation of Systemic Vascular Hyperpermeability in Severe Psoriasis by Circulating Vascular Endothelial Growth Factor. Archives of Dermatology, 138 (6). doi: 10.1001/archderm.138.6.791
Carmeliet, P., Jain, R. K. (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature, 473 (7347), 298–307. doi: 10.1038/nature10144
Forough, R. (2006). New frontiers in angiogenesis. Netherlands: Springer, 205. doi: 10.1007/1-4020-4327-9
Moens, S., Goveia, J., Stapor, P. C., Cantelmo, A. R., Carmeliet, P. (2014). The multifaceted activity of VEGF in angiogenesis – Implications for therapy responses. Cytokine & Growth Factor Reviews, 25 (4), 473–482. doi: 10.1016/j.cytogfr.2014.07.009
##submission.downloads##
Opublikowane
Numer
Dział
Licencja
Copyright (c) 2016 Людмила Анатольевна Болотная, Елена Игоревна Сариан, Анна Александровна Лопандина
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa 4.0 Międzynarodowe.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
